SCHEMBL6026423

SCHEMBL6026423

O=Cc1c(O)c(Cl)cc(Cl)c1OCCCCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGL P06737 1/20 0.41
ALB P02768 1/20 0.39
PPARA Q07869 4/20 0.37
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
PLAU P00749 1/20 0.36
LTB4R Q15722 1/20 0.36
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 2/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
TBXA2R P21731 1/20 0.34
FFAR4 Q5NUL3 2/20 0.34
KCNH2 Q12809 1/20 0.34
CACNA1C Q13936 1/20 0.34
SCN5A Q14524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6027201 0.78 RAB9A (0.43) ALBPPARARAB9AKDM4EFFAR4
SCHEMBL11008385 0.77 RAB9A (0.40) PYGLALBPPARATHRATHRB
SCHEMBL8217416 0.72 PPARA (0.41) PYGLALBPPARATHRATHRB
SCHEMBL7314481 0.72 FBP1 (0.38) PYGLALBPPARALTB4RMEN1
SCHEMBL6575170 0.72 PYGL (0.51) PYGLALBTHRATHRBPLAU
Hydrochloric Acid SCHEMBL7312508 0.71 FBP1 (0.38) PYGLALBPPARALTB4RMEN1
SCHEMBL7706321 0.70 PYGL (0.45) PYGLALBPPARATHRATHRB
SCHEMBL5339875 0.69 LMNA (0.49) PYGLALBPPARATHRATHRB
SCHEMBL9780778 0.69 KMT2A (0.62) PYGLPPARALTB4RMEN1KMT2A
SCHEMBL10495745 0.69 PLAU (0.41) PYGLTHRATHRBPLAURAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US claimed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP claimed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO claimed
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US disclosed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP disclosed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO disclosed
EP-0614357-A1 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-09-14 EP disclosed
WO-1994007479-A2 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-04-14 WO disclosed
EP-0054924-B1 PHARMACEUTICAL COMPOUNDS, THEIR PREPARATION AND USE THE WELLCOME FOUNDATION LIMITED (GB) 1986-08-06 EP disclosed
US-4535183-A PALLIATION OF SICKLE CELL ANEMIA, RESPIRATORY DISORDERS, HYPOXIA, RADIOSENSITIZATION OF TUMORS BURROUGHS WELLCOME CO. (US) 1985-08-13 US disclosed
EP-0054924-A2 Pharmaceutical compounds, their preparation and use THE WELLCOME FOUNDATION LIMITED (GB) 1982-06-30 EP disclosed